Home › Colite ulcerosa › Texas
Studi clinici su Colite ulcerosa nello stato di Texas
34 studi su Colite ulcerosa cercano partecipanti presso sedi nello stato di Texas.
Città nello stato di Texas
- Houston18 studi
- San Antonio16 studi
- Tyler14 studi
- Lewisville10 studi
- Lubbock9 studi
- Round Rock8 studi
- Dallas8 studi
- Garland8 studi
- Fort Worth7 studi
- League City6 studi
- The Woodlands5 studi
- Arlington4 studi
Testo ufficiale dello studio (inglese)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Novel Research - Bellaire /ID# 280925, Bellaire
- Ophthalmology Surgery Center of Dallas /ID# 284065, Dallas
- Gi Alliance - Texas Digestive Disease Consultants - Fort Worth /ID# 283977, Fort Worth
- e altri 9
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- The Clinical Trials Network CTNX LLC, El Paso
- Amel Med LLC, Georgetown
- Kelsey Research Foundation, Houston
- e altri 7
In reclutamentoFase 4
Età da 18 a 80 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06581328Confirmatory Clinical Study in Active Ulcerative Colitis
- Southern Star Research Institute, San Antonio
In reclutamentoFase 2
Età 16 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07296315A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- University of Texas - Southwestern Medical Center /ID# 271835, Dallas
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research, Baytown
- DHR Health Gastroenterology - Edinburg, Edinburg
- Baylor College of Medicine, Houston
- e altri 3
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Cedar Park
- Xencor Investigative Site, Denton
- Xencor Investigative Site, Garland
- e altri 8
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 013, Cedar Park
- Site 005, Garland
- Site 002, San Antonio
- e altri 2
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-024, Garland
- Site US-009, Georgetown
- Site US-030, Houston
- e altri 4
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- The University of Texas at Austin, Austin
- DFW Clinical Trials, Carrollton
- Victorium Clinical Research, Houston
- e altri 3
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07196748A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Cook Childrens Medical Center, Fort Worth
In reclutamentoFase 3
Età 3 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06663332A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Local Institution - 0103, Fort Worth
- Texas Children's Hospital, Houston
In reclutamentoFase 2/3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
- Tyler Research Institute, Tyler
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
- UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth
- e altri 2
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- One of a Kind Clinical Research Center - Kingwood, Kingwood
- Southern Star Research Institute, San Antonio
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Cook Children's Medical Center, Fort Worth
In reclutamentoFase 3
Età da 2 a 19 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Texas Digestive Disease Consultants - Cedar Park, Cedar Park
- GI Alliance - Dallas - Gaston Avenue, Dallas
- GI Alliance - Fort Worth, Fort Worth
- e altri 5
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Fort Worth, Fort Worth
- GI Alliance - Garland, Garland
- Integrity Advanced Therapeutics, Houston
- e altri 4
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- GI Alliance - Digestive Health Associates of Texas, Dallas
- The University of Texas Health Science Center at Houston, Houston
- GI Alliance - Mansfield, Mansfield
- e altri 4
In reclutamentoFase 4
Età da 18 a 65 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- GI Alliance - Lubbock - Site Number: 8400092, Lubbock
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
- Texas Digestive Disease Consultants, PLLC. dba GI Alliance - Southlake - Corporate Office - Site Number: 8400101, Southlake
- e altri 1
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07185009Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- GI Alliance - Digestive Health Associates of Texas - DHAT ( Site 0290), Garland
- GI Alliance - Lubbock ( Site 0288), Lubbock
- Caprock Gastro Research ( Site 0293), Lubbock
- e altri 3
In reclutamentoFase 3
Tutte le età · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06651281A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern Star Research Institute, LLC, San Antonio
- Tyler Research Institute, LLC, Tyler
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07577856A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- BAMC, Houston
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT04372108A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
- Texas Digestive Disease Consultants, Cedar Park
- Baylor College of Medicine, Houston
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 21 ago 2026 · NCT06636656An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Inquest Clinical Research - Site Number: 8400144, Baytown
- The University of Texas Southwestern Medical Center - Site Number: 8400098, Dallas
- Valley Institute of Research - Site Number: 8400004, Harlingen
- e altri 7
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07184996Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- University of Texas Southwestern, Dallas
- Baylor College of Medicine, Houston
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Amarillo Premier Research (Objective Health), Amarillo
- Digestive Research of Central Texas (Objective Health), Waco
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06571669An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Houston Endoscopy & Research Center, Houston
- BI Research Center, Houston
- Brooke Army Medical center, San Antonio
- e altri 2
In reclutamentoStudio osservazionale
Età da 18 a 64 · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- ACT-Midwest G1, Abilene
In reclutamentoFase 2
Età da 12 a 17 · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT05287126A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD)
- Tyler Research Institute, LLC, Tyler
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 22 mag 2026 · NCT06764615Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- M D Anderson Cancer Center, Houston
In reclutamentoStudio osservazionale
Età 18 e oltre · Tutti i sessi · Aggiornato il 20 mag 2026 · NCT04751396A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Texas Children's Hospital - Baylor - PIN, Houston
In reclutamentoFase 3
Età 2 e oltre · Tutti i sessi · Aggiornato il 7 mag 2026 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400023, Houston
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT06975722A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Dallas
- Mirador Therapeutics Selected Site, Garland
- Mirador Therapeutics Selected Site, Georgetown
- e altri 5
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 12 mar 2026 · NCT07113522Registry and Biorepository for IBD in Central Texas
- Dell Medical School, UT Austin, Austin
In reclutamentoStudio osservazionale
Età da 18 a 100 · Tutti i sessi · Aggiornato il 18 mag 2021 · NCT04617184Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.